2
Views
8
CrossRef citations to date
0
Altmetric
Original Article

The renal handling of sodium and water is not affected by the standard-dose Cisplatin treatment for testicular cancer

, , , , , & show all
Pages 455-459 | Received 06 Nov 1986, Accepted 22 Jan 1987, Published online: 17 Mar 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Fausto Petrelli, Karen Borgonovo, Mary Cabiddu, Mara Ghilardi & Sandro Barni. (2012) Risk of anti-EGFR monoclonal antibody-related hypomagnesemia: systematic review and pooled analysis of randomized studies. Expert Opinion on Drug Safety 11:sup1, pages S9-S19.
Read now
A.-L. Kamper, S. Strandgaard, N.-H. Holstein-Rathlou, P. P. Leyssac & O. Munck. (1988) The influence of body posture on lithium clearance. Scandinavian Journal of Clinical and Laboratory Investigation 48:6, pages 509-512.
Read now

Articles from other publishers (6)

Nepton Soltani, Mehdi Nematbakhsh, Fatemeh Eshraghi-Jazi, Ardeshir Talebi & Farzaneh Ashrafi. (2013) Effect of Oral Administration of Magnesium on Cisplatin-Induced Nephrotoxicity in Normal and Streptozocin-Induced Diabetic Rats. Nephro-Urology Monthly 5:4, pages 884-890.
Crossref
Rabia Hassam & Nirmalan Arulanantham. (2010) Drug-induced hypomagnesaemia. Adverse Drug Reaction Bulletin &NA;:262, pages 1007-1010.
Crossref
W. Stöhr, M. Paulides, S. Bielack, H. Jürgens, E. Koscielniak, R. Rossi, T. Langer & J.D. Beck. (2006) Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: A report from the late effects surveillance system. Pediatric Blood & Cancer 48:2, pages 140-147.
Crossref
H. Lajer & G. Daugaard. (1999) Cisplatin and hypomagnesemia. Cancer Treatment Reviews 25:1, pages 47-58.
Crossref
Gedske Daugaard & Ulrik Abildgaard. (1992) Evaluation of nephrotoxicity secondary to cytostatic agents. Critical Reviews in Oncology/Hematology 13:3, pages 215-240.
Crossref
Gedske Daugaard & Ulrik Abildgaard. (1989) Cisplatin nephrotoxicity. Cancer Chemotherapy and Pharmacology 25:1, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.